UBS Lux Equity Fund Biotech USD vs BNP Paribas China Equity

UBS Lux Equity Fund Biotech USD vs BNP Paribas China Equity

1. UBS Lux Equity Fund Biotech USD

  • Verdipapir

    UBS Lux Equity Fund Biotech USD P-acc

  • Gebyr

    2.25%

  • ISIN

    LU0069152568

  • Beholdninger

    10

2. BNP Paribas China Equity

  • Verdipapir

    BNP Paribas China Equity Classic USD Cap

  • Gebyr

    2.23%

  • ISIN

    LU0823426308

  • Beholdninger

    16

Fondsbeholdning

Vi har information om 14 beholdninger i UBS Lux Equity Fund Biotech USD, hvor den største beholdningen er Regeneron Pharmaceuticals (10.04%), etterfulgt av Vertex (9.35%) og Moderna (9.21%). Sammenligner vi med BNP Paribas China Equity har vi der 22 beholdninger hvor Alibaba Group Holding Ltd er største beholdningen (9.57%), etterfulgt av Tencent (9.35%) og Xiaomi (6.61%).

Alle beholdninger

Her sammenligner vi beholdningene i UBS Lux Equity Fund Biotech USD og BNP Paribas China Equity.

UBS Lux Equity Fund Biotech USD BNP Paribas China Equity
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Alibaba Group Holding Ltd
Kina
9.57 %
2. Vertex Pharmaceuticals Inc
9.35 %
2. Tencent Holdings Ltd
Kina
9.35 %
3. Moderna Inc
9.21 %
3. Xiaomi
Kina
6.61 %
4. Alnylam Pharmaceuticals Inc
6.96 %
4. Industrial and Commercial Bank of China Ltd Class H
Kina
4.22 %
5. AbbVie Inc
USA
5.53 %
5. Pop Mart International Group Ltd
Kina
4.17 %
6. Gilead Sciences Inc
USA
4.66 %
6. Meituan Class B
Kina
3.16 %
7. Amgen Inc
4.3 %
7. Trip.com Group Ltd
Singapore
2.91 %
8. BioNTech SE
4.13 %
8. Ping An Insurance Co
Kina
2.71 %
9. Karuna Therapeutics Inc
3.75 %
9. NetEase ADR
Kina
2.41 %
10. Royalty Pharma Plc
3.37 %
10. KE Holdings Inc ADR
Kina
2.4 %
- 11. JD.com Inc
Kina
2.22 %
- 12. Taiwan Semiconductor Manufacturing Company
Taiwan
1.7 %
- 13. Pinduoduo Inc
Kina
1.68 %
- 14. China Yangtze Power Co Ltd Class A
Kina
1.64 %
- 15. BYD Co Ltd Class H
Kina
1.52 %
- 16. Sunny Optical Technology Company Ltd
Kina
1.27 %

Listen over fondsbeholdning ble sist oppdatert 4 juni 2025.